R&D at Aposcience AG is performed in close collaboration with the Christian Doppler Laboratory for the Diagnosis & Regeneration of Cardiac and Thoracic Diseases at the Medical University of Vienna. A further collaboration exists with the University of Kaposvár (Hungary) for demonstrating the in vivo activity of APO-1 (APOSECTM) in large animal models.

For the development of the manufacturing process the company cooperates closely with the Blood Donation Service of the Austrian Red Cross in Linz.

Latest News

Approval of DSMB for Lead In-Phase and Go-Ahead for MARSYAS II Main Study



Approval for clinical phase II study in DFU by German health agency PEI